series-a
Stage
3
Investors
About
Pretzel Therapeutics is dedicated to developing life-changing medicines with a broad pipeline of first-in-class treatments addressing novel targets within the mitochondria, the primary organelles responsible for producing and regulating cellular energy. By harnessing cellular energetics, they are ushering in a new treatment paradigm for a range of conditions spanning neurological, muscular atrophies, metabolic and rare diseases.
Explore Pretzel Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.